Ultrasound showdown: which test best spots returning liver cancer?
NCT ID NCT07600346
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two contrast-enhanced ultrasound scoring systems (LI-RADS and ESCULAP) to see which one better detects recurrent liver cancer in 105 patients who have had surgery for hepatocellular carcinoma. The goal is to improve diagnostic accuracy for new liver lesions. Participants will receive a contrast-enhanced ultrasound, and results will be checked against biopsy or follow-up data.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Contrast-enhanced ultrasound (with injected contrast agent)
- What this could lead to
- If this study succeeds, it could help doctors more accurately detect returning liver cancer after surgery, potentially leading to earlier treatment.
- What could go wrong
- This is an early-stage diagnostic comparison study, not a treatment trial. The results may not change current practice, and the methods may not work equally well for all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONTRAST ENHANCED ULTRASOUND are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ultrasound quality: experts aim to standardize liver imaging
- Could a simple ultrasound replace liver biopsies for this rare disease?
- Can a simple ultrasound spot hidden pregnancy risks?
- New ultrasound model may guide thyroid cancer surgery without extra scans
- Ultrasound breakthrough: predicting cancer therapy success without needles
- New ultrasound technique may spot breast cancer treatment success early